Insulin should be affordable for all
Make Insulin Affordable
CBS – brief report on insulin affordability and a mother’s grief
“Insulin’s High Cost Leads To Lethal Rationing” – NPR story that conveys the tragic story of a young man’s life cut short because he couldn’t afford his insulin. Sign the ADA Petition to make insulin affordable.
The Insulin Wars ( How insurance companies farm out their dirty work to doctors and patients) – The New York Times
We can make a difference starting today!
Sign the Petition by American Diabetes Association
- More than 30 million Americans have diabetes and approximately 7.4 million depend on insulin.
- Diagnosed diabetes in the U.S. cost $327 billion in 2017, a 26 percent increase in five years.
- Between 2002-2013, the average price of insulin nearly tripled, creating financial hardships for people who rely on it to survive.
- In much of Europe, insulin costs about a sixth of what it does in the United States.
- Some people with diabetes are cutting back on or skipping doses of insulin – or foregoing other necessities to pay for insulin – which puts their lives and health at risk.
- People with diabetes are at significant risk for serious complications including kidney failure, heart disease, stroke, blindness and lower-limb amputations.
- Sign the ADA Petition to Make Insulin Affordable
ADA Pharmacologic Approaches to Glycemic Treatment 2019.
Insulin Cost – Standard 9 acknowledges that increasing insulin expense is contributing to steadily growing out of pocket costs. As such, the ADA states that for people with type 2 on insulin,
“NPH and Regular insulin may be the appropriate choice of therapy and clinicians should be familiar with it’s use.”
This section also includes a Average Wholesale Pricing (AWP) for oral diabetes medications and insulin which are very enlightening a worth a review.
Switch from Analogue to Human Insulin Reduces Part D Coverage Gap Risk for Medicare Beneficiaries – Presenter, Jing Luo, MD, MPH Luo J, et al. 4-OR. Presented at: American Diabetes Association 78th Scientific Sessions; June 22-26, 2018; Orlando, Fla.
Affordability Working Group: Conclusions and Recommendations – Diabetes Care, May 2018
List prices of insulin have risen precipitously
in recent years. Between 2002 and
2013, the average price of insulin nearly
tripled.
c The current pricing and rebate system
encourages high list prices.
+ As list prices increase, the profits of
the intermediaries in the insulin
supply chain (wholesalers, PBMs,
pharmacies) increase since each may
receive a rebate, discount, or fee calculated
as a percentage of the list price.
![](/wp-content/uploads/2023/01/insta-png-v5.png")
